Back

Reduced mitochondrial aldehyde dehydrogenase-2 activity and protein levels in left ventricular myocardium of dogs with Heart Failure

28 May 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Basic Science and Translational Mitochondria HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Hani Sabbah

Henry Ford Hospital, Detroit (United States of America)

20 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor N. Pavo (Vienna, AT)
Abstract
Presentation thumbnail
Presentation thumbnail
Doctor H. Lee (Pusan, KR)
Abstract
Presentation thumbnail
Doctor A. Galluzzo (Rivoli, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Basic Science and Translational

The Event

Event poster

Heart Failure 2019

28 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Treatment of cardiomyocytes isolated from left ventricular myocardium of dogs with chronic heart failure with ALDA-1, an activator of aldehyde dehydrogenase-2, improves mitochondrial function
28 August 2023
thumbnail
Congress Presentation
Trimethylamine N-Oxide produced by the gut microbiota is predictor of left ventricle reverse remodeling in patients with recent-onset heart failure
20 May 2023
thumbnail
Congress Presentation
East Asian variant aldehyde dehydrogenase Type 2 genotype exacerbates myocardial ischemia/reperfusion injury in men among patients with ST-segment elevation myocardial infarction -sex differences-
28 August 2020
thumbnail
Congress Presentation
Heart failure and energy metabolism: the role of fatty acid transport proteins and cardiac lipotoxicity
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources